HCPCS J1454 is officially defined as "Injection, fosnetupitant 235 mg and palonosetron 0.25 mg." HCPCS J1454 is referenced in 3 tracked payer policy changes from Highmark, Arkansas Blue Cross Blue Shield, and 1 other payer. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for HCPCS J1454 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.
Related
Get alerts for changes like this
Save a search and receive a daily digest whenever a new policy change matches your filters.